Abstract:Objective To investigate the incidence of hypoglycemia in type 2 diabetic patients with well-controlled glucose levels (HbA1c<7.0%) by using a continuous glucose monitoring system (CGMS), and evaluate the clinical application value of CGMS. Methods A total of 102 type 2 diabetic patients with HbA1c<7.0% were recruited in Xindu District and Longquanyi District of Chengdu between January 2016 and January 2017. Each subject received a continuous glucose monitoring for 3 consecutive days and was instructed to self-monitoring of blood glucose (SMBG) with finger-stick blood glucose 4 times per day. The accuracies of CGMS and SMBG were analyzed by Clarke error grid analysis. The demographic and laboratory data were collected to analyze the incidence of hypoglycemia and its risk factors. The control targets of glucose fluctuation were explored by using receiver operating characteristic curve for avoiding hypoglycemia. T test was used for analyzing measurement data and chi-square test for count data. Results (1) Of 102 subjects, 49 patients experienced hypoglycemia including 31 cases with nocturnal hypoglycemia. The mean blood glucose (MBG) was (6.9 ± 1.1) mmol/L and the standard deviation of blood glucose (SDBG) was (1.4 ± 0.7) mmol/L. (2) Taking out 946 pairs of matched glucose measurements from SMBG and CGMS, Clarke error grid analysis showed that 99.05%of the readings from CGMS fell into the clinical acceptable zone A (clinical exactness) and zone B (benign error), further findings presented that 82.05%of the readings from CGMS fell into zone A and zone B when exploring hypoglycemia consistence. (3) MBG, SDBG, continuous overlapping net glycemic action (CONGA), low blood glucose index (LBGI), mean of daily differences (MODD), mean amplitude of glycemic excursions (MAGE), M-value and largest amplitude of glycemic excursion (LAGE) had significant differences between the hypoglycemia and non-hypoglycemia group (t=1.807-33.957, all P<0.05). (4) Forty-nine patients experienced 140 events with a glucose level<3.9 mmol/L recorded in CGMS. The incidence of hypoglycemia presented highest from 22:00pm to 6:00am (45.00%). The duration time of single hypoglycemia event was 35 (P2525.00,P7545.00) min. (5) Episodes of hypoglycemia and LBGI significantly correlated with professional status (r=-0.249,-0.202, P<0.05, respectively) and monthly income (r=-0.295,-0.254, P<0.05, respectively). Logistic regression analysis indicated that LBGI was independently correlated with hypoglycemia (r=2.618, OR=13.712, P<0.05). (6) Control targets analyzed by ROC curve for avoiding hypoglycemic events were MBG<6.93 mmol/L, SDBG<1.38 mmol/L, LBGI<0.84 mmol/L and MODD<1.44 mmol/L, respectively. Conclusions Hypoglycemia presents high in type 2 diabetes mellitus patients with good glycemic control. CGMS has good accuracy and can monitor hypoglycemia which is not easily to be detected by SMBG. It can be used to provide a more reasonable treatment plan for type 2 diabetes mellitus patients.

Effect of Real-time Continuous Glucose Monitoring on Hypoglycemia in Adult Type 1 Diabetes.

Effects of Intermittently Scanned Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Glycaemic Control: A Multi-Centre Randomized Controlled Trial

Control of Blood Glucose Fluctuation by Real-Time Continuous Glucose Monitoring in Type 2 Diabetes

Dynamics of HbA1c, BMI and rates of severe hypoglycemia in 4,434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring.

Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring

Impact in real-world of intermittent-scanned continuous glucose monitoring with alarms on hypoglycemia and its recognition in type 1 diabetes

Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial

Evaluation of Hypoglycemia in Type 2 Diabetic Patients with Well-Controlled Glucose Levels by Continuous Glucose Monitoring System

Comparing the Effectiveness of Continuous Subcutaneous Insulin Infusion with Multiple Daily Insulin Injection for Patients with Type 1 Diabetes Mellitus Evaluated by Retrospective Continuous Glucose Monitoring: A Real-World Data Analysis.

Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting

Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Exploring the Continuous Glucose Monitoring in Pediatric Diabetes: Current Practices, Innovative Metrics, and Future Implications

Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry

Clinical Effectiveness of Continuous Glucose Monitoring in Pregnancies Affected by Type 1 Diabetes

[Evaluating the Feature of Hypoglycemia Detected by Continuous Glucose Monitoring System During Temporary Continuous Subcutaneous Insulin Infusion in Type 2 Diabetes Patients].

Real-time continuous glucose monitoring immediately after severe hypoglycaemia requiring emergency medical services: A randomised controlled trial

Research progress of real-time continuous glucose monitoring technology

Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control

Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications